AHK-Cu vs Palmitoyl Tripeptide-5
Research Verdict
Neither compound has a universal evidence advantage. Research distinction: Research into copper-delivery peptide mechanisms at the cellular level vs. TGF-beta-pathway collagen stimulation research with manufacturer-level formulation data available.
Quick Answers
Which is better, AHK-Cu or Palmitoyl Tripeptide-5?
Neither compound has a universal evidence advantage. Research distinction: Research into copper-delivery peptide mechanisms at the cellular level vs. TGF-beta-pathway collagen stimulation research with manufacturer-level formulation data available.
What is the key difference between AHK-Cu and Palmitoyl Tripeptide-5?
Palmitoyl tripeptide-5 mimics TGF-beta signaling for collagen synthesis; copper-AHK delivers copper via a peptide carrier - different mechanisms, both unvalidated in humans.
Evidence Comparison
Palmitoyl tripeptide-5: manufacturer-sponsored data (Sederma) showing TGF-beta mimetic collagen stimulation. Copper-AHK: single in vitro paper (Kang 2009). Both are weak; palmitoyl tripeptide-5 has slightly more formulation data.
Evidence Context Favoring AHK-Cu
Research into copper-delivery peptide mechanisms at the cellular level.
Evidence Context Favoring Palmitoyl Tripeptide-5
TGF-beta-pathway collagen stimulation research with manufacturer-level formulation data available.
Side-by-Side Snapshot
| Evidence grade | AHK-Cu: Level D Palmitoyl Tripeptide-5: Level D |
|---|---|
| Research status | AHK-Cu: Preclinical Palmitoyl Tripeptide-5: Preclinical |
| Primary category | AHK-Cu: Skin & Beauty Palmitoyl Tripeptide-5: Skin & Beauty |
| Cited studies | AHK-Cu: 2 Palmitoyl Tripeptide-5: 2 |